Kwality Pharmaceuticals Ltd receives SFDA GMP approval for 2 units

Kwality Pharmaceuticals Limited has successfully obtained SFDA GMP Approval for the 2 audited units.

Unit-1 - Amritsar - Generic Injectable facility (Sterile Products ; Lyopholised Injectables, Small Volume Liquids, Dry powder for injection and terminally sterilized small volume liquids) and Unit-2 - Amritsar - Beta- lactam (Sterile Products; Penicillins and Dry Powder Injectables).

SFDA is an esteemed regulatory agency which is now a PIC/s member state.

This certification will open new markets for the Kwality Pharma such as Saudi Arabia, UAE, Jordan, Bahrain, Kuwait, Oman and Qatar and the 50+ PIC/S countries as well through mutual reorganization.

As Saudi Arabia is considered as reference state for registrations across GCC markets, products under registration in the market can be registered across the cluster of 7+ GCC markets simultaneously.

Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 900.65 as compared to the previous close of Rs. 857.80. The total number of shares traded during the day was 17857 in over 372 trades.

The stock hit an intraday high of Rs. 900.65 and intraday low of 866.95. The net turnover during the day was Rs. 15918327.00.

Source : Equity Bulls

Keywords

KwalityPharmaceuticals INE552U01010 SFDA GMPApproval 2Units